NovoCure Limited (NVCR) Stock Overview
NASDAQ · Healthcare · Medical Devices
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About NovoCure Limited
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. Its TTFields devices…
Source: Yahoo Finance
Sector & Industry
NovoCure Limited operates in the Healthcare sector, within the Medical Devices industry group. It is listed on the NASDAQ exchange.
NovoCure Limited at a Glance
| Company | NovoCure Limited |
| Ticker | NVCR |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $17.94 |
| Market cap | $2.09B |
| P/E ratio (trailing) | — |
| EPS (trailing) | -$1.30 |
| 52-week high | $21.45 |
| 52-week low | $9.82 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 1.01 |
| Return on equity (ROE) | -43.22% |
| Debt-to-equity | 69.04% |
| Average volume | 1.58M |
| Shares outstanding | 116.45M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Employees | 1,605 |
| Country | Switzerland |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Frequently Asked Questions
- What is NovoCure Limited's current P/E ratio?
- NovoCure Limited (NVCR) has a trailing P/E ratio of — as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is NovoCure Limited's market capitalisation?
- NovoCure Limited's market cap is $2.09B based on our latest snapshot. See how it ranks by market cap →
- What is NVCR's 52-week range?
- Over the past 52 weeks, NVCR has traded between $9.82 and $21.45. What does the 52-week range mean? →
- How volatile is NovoCure Limited compared to the market?
- NovoCure Limited has a beta of 1.01, meaning it has historically moved more than the broader market. What does beta measure? →
- Does NovoCure Limited pay a dividend?
- NovoCure Limited does not currently pay a dividend according to our latest data.
- What exchange is NVCR listed on?
- NVCR is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is NovoCure Limited in?
- NovoCure Limited is classified in the Healthcare sector. Compare with Healthcare peers →
For compound interest, percentage change and other investing maths, try our free online calculators.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Philip Fisher on what makes a business worth owning for the long term.
Check Price →Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →